Dopaminergic Medication Modulates Learning from Feedback and Error-Related Negativity in Parkinson's Disease: A Pilot Study - PubMed
- ️Fri Jan 01 2016
Dopaminergic Medication Modulates Learning from Feedback and Error-Related Negativity in Parkinson's Disease: A Pilot Study
Chiara Volpato et al. Front Behav Neurosci. 2016.
Abstract
Dopamine systems mediate key aspects of reward learning. Parkinson's disease (PD) represents a valuable model to study reward mechanisms because both the disease process and the anti-Parkinson medications influence dopamine neurotransmission. The aim of this pilot study was to investigate whether the level of levodopa differently modulates learning from positive and negative feedback and its electrophysiological correlate, the error related negativity (ERN), in PD. Ten PD patients and ten healthy participants performed a two-stage reinforcement learning task. In the Learning Phase, they had to learn the correct stimulus within a stimulus pair on the basis of a probabilistic positive or negative feedback. Three sets of stimulus pairs were used. In the Testing Phase, the participants were tested with novel combinations of the stimuli previously experienced to evaluate whether they learned more from positive or negative feedback. PD patients performed the task both ON- and OFF-levodopa in two separate sessions while they remained on stable therapy with dopamine agonists. The electroencephalogram (EEG) was recorded during the task. PD patients were less accurate in negative than positive learning both OFF- and ON-levodopa. In the OFF-levodopa state they were less accurate than controls in negative learning. PD patients had a smaller ERN amplitude OFF- than ON-levodopa only in negative learning. In the OFF-levodopa state they had a smaller ERN amplitude than controls in negative learning. We hypothesize that high tonic dopaminergic stimulation due to the dopamine agonist medication, combined to the low level of phasic dopamine due to the OFF-levodopa state, could prevent phasic "dopamine dips" indicated by the ERN needed for learning from negative feedback.
Keywords: Parkinson’s disease; dopamine agonists; error-related negativity; levodopa; reward learning.
Figures

The plot shows the percentage (%) of correct responses in the Testing Phase. Negative Learning = percentage of avoidance of B responses; Positive Learning = percentage of choice of A responses. PD, Parkinson’s disease. *Indicates significant difference (p < 0.05).

Grand-average of response-locked event-related potentials (ERPs) to error and correct trials in (A) controls, (B) PD patients ON-levodopa and (C) PD patients OFF-levodopa at Cz. PD, Parkinson’s disease.
Similar articles
-
Mathar D, Wilkinson L, Holl AK, Neumann J, Deserno L, Villringer A, Jahanshahi M, Horstmann A. Mathar D, et al. Cortex. 2017 May;90:149-162. doi: 10.1016/j.cortex.2016.09.004. Epub 2016 Sep 19. Cortex. 2017. PMID: 27751503
-
Effects of levodopa on stimulus-response learning versus response selection in healthy young adults.
Vo A, Seergobin KN, MacDonald PA. Vo A, et al. Behav Brain Res. 2017 Jan 15;317:553-561. doi: 10.1016/j.bbr.2016.10.019. Epub 2016 Oct 12. Behav Brain Res. 2017. PMID: 27743941 Clinical Trial.
-
Seer C, Lange F, Loens S, Wegner F, Schrader C, Dressler D, Dengler R, Kopp B. Seer C, et al. Sci Rep. 2017 Jan 24;7:41222. doi: 10.1038/srep41222. Sci Rep. 2017. PMID: 28117420 Free PMC article.
-
[New therapeutic strategy for Parkinson's disease based on pharmacological profiles].
Ogawa N. Ogawa N. Nihon Rinsho. 1997 Jan;55(1):43-51. Nihon Rinsho. 1997. PMID: 9014422 Review. Japanese.
-
Adjuncts to levodopa therapy: dopamine agonists.
Poewe W. Poewe W. Neurology. 1998 Jun;50(6 Suppl 6):S23-6; discussion S44-8. doi: 10.1212/wnl.50.6_suppl_6.s23. Neurology. 1998. PMID: 9633683 Review.
Cited by
-
LoTemplio SB, Lopes CL, McDonnell AS, Scott EE, Payne BR, Strayer DL. LoTemplio SB, et al. Front Hum Neurosci. 2023 Apr 4;17:1150244. doi: 10.3389/fnhum.2023.1150244. eCollection 2023. Front Hum Neurosci. 2023. PMID: 37082151 Free PMC article. Review.
-
Mann T, Zilles K, Klawitter F, Cremer M, Hawlitschka A, Palomero-Gallagher N, Schmitt O, Wree A. Mann T, et al. Front Neuroanat. 2018 Aug 10;12:65. doi: 10.3389/fnana.2018.00065. eCollection 2018. Front Neuroanat. 2018. PMID: 30147647 Free PMC article.
-
Risky decision-making and affective features of impulse control disorders in Parkinson's disease.
Martini A, Ellis SJ, Grange JA, Tamburin S, Dal Lago D, Vianello G, Edelstyn NMJ. Martini A, et al. J Neural Transm (Vienna). 2018 Feb;125(2):131-143. doi: 10.1007/s00702-017-1807-7. Epub 2017 Nov 8. J Neural Transm (Vienna). 2018. PMID: 29119257 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous